Evidence map›Paper›PMID 11803442›Full record

ReviewMolecular psychiatry2002

Cocaine, reward, movement and monoamine transporters.

G R Uhl, F S Hall, I Sora

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular psychiatry, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
5.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 214 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Amphetamine-like Neurochemical and Cardiovascular Effects ofThe Journal of pharmacology and experimental therapeutics · 2021
    Article
  10. Article
  11. Roles Played by the NaNeurochemical research · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Cyclin-Dependent Kinase Inhibitor 1a (p21) Modulates Response to Cocaine and Motivated Behaviors.The Journal of pharmacology and experimental therapeutics · 2016
    Article
  19. Classic Studies on the Interaction of Cocaine and the Dopamine Transporter.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2015
    Article
  20. Review

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

G R UhlMolecular Neurobiology Branch, NIDA-IRP, NIH, Baltimore, MD 21224, USA. guhl@intra.nida.nih.gov
F S Hall
I Sora
National Institute on Drug Abuse · US

Funding

Genetic Approaches To Characterizing Drug Responses And Vulnerabilities: MiceZIADA000165 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI UHL, GEORGE RICHARD · 2009 to 2016
$7.9M
GENETIC APPROACHES TO CHARACTERIZING DRUG RESPONSES AND VULNERABILITIES: HUMANSZ01DA000401 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI UHL, GEORGE RICHARD · 1997 to 2008
$4.6M
Genetic Approaches To Characterizing Drug Responses And Vulnerabilities: HumansZIADA000401 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI UHL, GEORGE RICHARD · 2009 to 2015
$3.4M
GENETIC APPROACHES TO CHARACTERIZING DRUG RESPONSES AND VULNERABILITIES: MICEZ01DA000165 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI UHL, GEORGE RICHARD · 1995 to 2008
$1.5M
6 · The paper itself

Abstract

Recent evidence enriches our understanding of the molecular sites of action of cocaine reward and locomotor stimulation. Dopamine transporter blockade by cocaine appears a sufficient explanation for cocaine-induced locomotion. Variation in DAT appears to cause differences in locomotion without drug stimulation. However, previously-held views that DAT blockade was the sole site for cocaine reward have been replaced by a richer picture of multitransporter involvement with the rewarding and aversive actions of cocaine. These new insights, derived from studies of knockout mice with simultaneous deletions and/or blockade of multiple transporters, provide a novel model for the rewarding action of this heavily-abused substance and implicate multiple monoamine systems in cocaine's hedonic activities.

Indexed as

RewardAnimalsBrainCarrier ProteinsCocaineCocaine-Related DisordersDopamineDopamine Plasma Membrane Transport ProteinsGenetic Predisposition to DiseaseGenetic VariationHumansMembrane GlycoproteinsMembrane Transport ModulatorsMembrane Transport ProteinsMiceMice, KnockoutCarrier ProteinsCocaineDopamineDopamine Plasma Membrane Transport ProteinsMembrane GlycoproteinsMembrane Transport ModulatorsMembrane Transport ProteinsNerve Tissue ProteinsNorepinephrineNorepinephrine Plasma Membrane Transport ProteinsSerotoninSerotonin Plasma Membrane Transport ProteinsSLC6A2 protein, humanSlc6a2 protein, mouseSLC6A3 protein, humanSlc6a3 protein, mouseSLC6A4 protein, humanSlc6a4 protein, mouseSymporters

Identifiers

PMID11803442
OpenAlexW2037646583

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.